Back
Ocuphire Pharma Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
33
OCUP
Ocuphire Pharma
Last Price:
1.41
Seasonality Move:
-20.18%
Sell
36
SYRS
Syros Pharmaceuticals
Last Price:
1.98
Seasonality Move:
-18.92%
Sell
33
Ocuphire Pharma (OCUP)
is a Sell
Is Ocuphire Pharma a Buy, Sell or Hold?
- The current Ocuphire Pharma [OCUP] share price is $1.33. The Score for OCUP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- OCUP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Syros Pharmaceuticals (SYRS)
is a Sell
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $1.98. The Score for SYRS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SYRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OCUP Stock Price Chart
What is Ocuphire Pharma's stock price today?
-
The Ocuphire Pharma share price today is $1.33
The current trend is relatively stagnant and OCUP is experiencing selling pressure, which indicates risk of future bearish movement.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $1.98
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing slight selling pressure.
OCUP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 47.92 | Sell |
| Chaikin Money Flow: | -53548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.22 - 1.32) | Buy |
| Bollinger Bands (100): | (1.38 - 1.88) | Sell |
SYRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 40.41 | Sell |
| Chaikin Money Flow: | -47118 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.81) | Buy |
| Bollinger Bands (100): | (2.78 - 6.2) | Sell |
OCUP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.27 | Buy |
| 50-day SMA: | 1.57 | Sell |
| 200-day SMA: | 2.03 | Sell |
| 8-day EMA: | 1.29 | Buy |
| 20-day EMA: | 1.31 | Buy |
| 50-day EMA: | 1.46 | Sell |
| 200-day EMA: | 2.03 | Sell |
SYRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.76 | Buy |
| 20-day SMA: | 1.67 | Buy |
| 50-day SMA: | 3.67 | Sell |
| 200-day SMA: | 5.34 | Sell |
| 8-day EMA: | 1.83 | Buy |
| 20-day EMA: | 2.01 | Sell |
| 50-day EMA: | 3.07 | Sell |
| 200-day EMA: | 4.58 | Sell |
Ocuphire Pharma Earnings Growth & OCUP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.24 per share, and an increase next year of $0.78 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.47 per share, a decrease next quarter of $0.12 per share, an increase this year of $2.67 per share, and a decrease next year of $0.64 per share.
Ocuphire Pharma Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syros Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||